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Abstract 
Background: Smoking is a known risk factor for cardiovascular morbidity and mortality, but 
several Korean studies have shown differing results on the association of current smoking 
status and the risk of cardiovascular disease (CVD). The aim of the present study was to 
investigate the association between smoking status and CVD (myocardial infarction and 
stroke) using national representative population-based samples. The aim was also to 
investigate the effects of hidden smokers on the association between CVD and smoking. 
Methods: Data were acquired from 28,620 participants (12,875 men and 15,745 women), age 
19 years or older, who participated in the Korea National Health and Nutrition Examination 
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Survey (KNHANES) conducted from 2008 to 2016.  
Results: The multivariable logistic regression analysis showed that ex-smoking status was 
correlated with CVD when self-reported (odds ratio [OR]: 1.62; 95% confidence interval 
[CI]: 1.20–2.19) and for survey-cotinine verified-smoking status (OR: 1.57; 95% CI: 1.20–
2.19). Interestingly, the present study showed current smoking was not significantly 
associated with CVD. For the effect of sex on smoking and CVD, self-reported and survey-
cotinine-verified ex-smoking status were correlated with CVD in males (OR: 1.45; 95% CI: 
1.04–2.04 and OR: 1.43; 95% CI: 1.02–2.02) and in females (OR: 2.74; 95% CI: 1.59–4.71 
and OR: 2.92; 95% CI: 1.64–5.18). The ratios of cotinine-verified to self-reported smoking 
rates were 1.95 for women and 1.08 for men. 
Conclusions: In the current study, while ex-smoking status was significantly associated with 
CVD, current smoking status was not. Female ex-smoking status had a higher adjusted odds 
ratio for CVD than males compared to non-smoking status. An effect of hidden female 
smoking was also found on the association between smoking status and CVD in Korean 
adults. 
Key words: smoking, myocardial infarction, stroke, hidden smoker 
 
Introduction 
Smoking is a known risk factor of cardiovascular morbidity and mortality [1]. However, 
while more than 4000 chemical substances contained in a cigarette are known to have adverse 
effects on various cardiovascular diseases (CVD) [2], the pathophysiological mechanisms 
underlying the association between smoking and CVD have not been fully elucidated. 
The CHANCES consortium (Consortium on Health and Ageing: Network of Cohorts in 
Europe and the United States) study showed a strong relationship between tobacco smoking 
and CVD [3]. This study used data from 10 cohort studies that showed a cardiovascular 
mortality hazard ratio of 2.07 (95% confidence interval [CI]: 1.82–2.36) for current smokers 
and 1.37 (95% CI: 1.25–1.49) for former smokers compared to participants who had never 
smoked. Another meta-analysis study based on prospective studies showed that the relative 
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risk (RR) of sudden cardiac death due to CVD, including coronary heart disease and stroke, 
was 3.06 (95% CI: 2.46–3.82) for current smokers and 1.38 (95% CI: 1.20–1.60) for former 
smokers compared to participants who had never smoked [4].  
Moreover, the INTERHEART study showed that current smoking status (odds ratio [OR] 
2.87) was significantly associated with myocardial infarction (MI) [5], and a UK biobank 
study showed that the hazard ratios for MI were 3.46 (95% CI: 3.02–3.98) in female current 
smokers and 2.23 (2.03–2.44) in male current smokers [6]. One meta-analysis study showed 
that the pooled relative risk of stroke associated with current smoking status vs. non-smoking 
status was 1.67 (95% CI: 1.49–1.88) in men and 1.83 (95% CI: 1.58–2.12) in women [7]. 
However, several Korean studies showed contrasting results on the association between 
current smoking status and CVD risk in adults [8, 9]. A national study showed that smoking 
status was significantly associated with stroke (RR: 1.060, 95% CI: 1.022–1.100) but not MI 
(RR: 1.004, 95% CI: 0.958–1.051) [8]. In addition, another national study showed that, 
compared to a non-smoking group of Korean adult males, the ORs (95% CI) for physician-
diagnosed stroke and MI in a current smoker group were 0.84 (0.74–0.94) and 0.96 (0.82–
1.12), respectively, and 1.38 (1.24–1.53) and 1.45 (1.26–1.67), respectively, in a past smoker 
group [9]. 
Recently, a report showing that ratios of cotinine-verified to self-reported smoking rates 
were 2.36 for women and 1.12 for men in Korea [10]. In a previous report, an effect was 
found of hidden female smoking on the association between smoking and hypertension in 
Korean adults [11]. It is currently proposed that contradictory results from other countries 
may be due to hidden female smokers. 
Therefore, the first aim of the study was to investigate the association between smoking 
status and cardiovascular disease using different nationally representative population-based 
samples. The second aim was to investigate the effects of hidden female smokers on the 
association between cardiovascular disease and smoking in Korean adults.   
 
Methods 
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Study population 
This study was based on data obtained from the 2008–2016 KNHANES study. 
KNHANES, which was a cross-sectional survey designed to examine the health and 
nutritional status of the non-institutionalized Korean population.  
Of the total 76,909 KNHANES participants, 48,289 participants were excluded due to the 
following criteria: under 18 years old, no smoking history, no MI information, no stroke 
information, no urine cotinine test, no history of renal failure information, or serum creatinine 
≥ 1.5 mg/dL. The remaining 28,620 participants (12,875 men and 15,745 women) were 
included in the final analysis.  
 
General characteristics, anthropometry, and laboratory tests 
The contents of the questionnaire used in KNHANES included sex, age, marital status, 
employment status, education level, monthly family income, number of household members, 
residence area, and body mass index (BMI). The questionnaire also ascertained the presence 
of or history of hypertension, diabetes, MI, and stroke. The respondents’ residential areas 
were categorized as urban (an administrative division of a city) or rural (not classified as an 
administrative division of a city). The definition of a city in Korea is a place where more than 
50,000 people live. Monthly family income indicates monthly-equalized family income and 
was calculated by dividing the total family income by the square root of the number of 
household members. In KNHANES, monthly family income was classified into quartiles in 
order to determine the monthly household income level (1: low, 2: middle low, 3: middle 
high, and 4: high). Education level was defined as less than middle school, middle school, 
high school, and college or more. BMI was calculated as weight (kilograms) divided by 
height (meters squared) and was categorized into three groups: normal weight (< 23 kg/m2), 
overweight (23–25 kg/m2), and obese (≥ 25 kg/m2) [12]. 
Cigarette smoking status was divided into three categories: smoker, ex-smoker, and never 
smoked. Respondents who reported having consumed ≥ 100 cigarettes in their lifetime or 
responded “yes” to the question, “Do you smoke cigarettes now?” were regarded as smokers. 
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Participants answering “no” to the same question were classified as ex-smokers. Respondents 
who consumed < 100 cigarettes in their lifetime were regarded as never having smoked. 
Urinary cotinine was measured by tandem mass spectrometry with a tandem mass API 
4000 (Applied Biosystems, Carlsbad, CA, USA) and by gas chromatography and mass 
spectrometry with a Perkin Elmer Clarus 600T (PerkinElmer, Turku, Finland). Respondents 
with urinary cotinine concentrations ≥ 50 ng/mL were considered cotinine-verified smokers, 
and those with cotinine levels < 50 ng/mL were cotinine-verified non-smokers [13]. 
To define MI and stroke, the following survey question was used in this study: “Have you 
ever been diagnosed with myocardial infarction or stroke by a physician?” For convenience, 
CVD to MI and stroke were limited. In a similar questionnaire, blood pressure (BP) 
measurements and medication history were used to define hypertension with the following 
question: “Have you ever been diagnosed with hypertension by a physician or take a 
medicine now?” Seated BP was measured using a standardized automated oscillometric 
device after a 5-min rest period. If BP was abnormally high or low, BP was reassessed with a 
mercury sphygmomanometer by a trained nurse. Hypertension was defined as having 
elevated BP (systolic BP [SBP] ≥ 140 mmHg and/or diastolic BP [DBP] ≥ 90 mmHg). 
Participants currently prescribed anti-hypertensive medication were also considered to be 
hypertensive. Diabetes was defined as a fasting blood glucose (FBG) of 126 mg/dL. 
Participants who reported being diagnosed with diabetes by a physician and prescribed 
diabetes medication including insulin were also considered to be diabetic. 
To better understand the link between MI, stroke, and smoking, a new variable was created 
for defining smoking status (SCS, survey-cotinine-verified smoking status) (Table 1). It was 
assumed that smoking in this variable included all smoking types, including light, 
intermittent, passive, hidden, and active heavy smoking (Table 1). 
Statistical analysis  
All statistical analyses was conducted using the Statistical Package for the Social Sciences 
(SPSS) complex sample procedures since KNHANES data were collected through a 
representative, stratified, and clustered sampling method. Values are presented as number of 
participants or estimates (95% CI). Data are expressed as the mean ± standard deviation (SD) 
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and as the median for continuous variables and as percentages (%) for categorical variables. 
Calculations of crude odd ratios and 95% CI values for CVD in relation to potential risk 
factors were performed using univariable logistic regression models. Finally, multivariable 
logistic regression analysis was carried out to identify the relationships between risk factors 
and CVD to evaluate the relationship of self-reported and cotinine-verified smoking status 
with CVD. Sex, age, marital status, employment status, education level, monthly family 
income, number of household members, residence area, smoking status, BMI, presence of 
hypertension and presence of diabetes were corrected for in the final multivariable logistic 
regression model. 
Statistical analysis was conducted using SPSS version 21.0 (SPSS Inc. Chicago, IL, US). 
For all analyses, p values were two-tailed, and a p value < 0.05 was considered statistically 
significant. 
 
Results 
Clinical characteristics 
A total of 28,620 subjects from the KNHANES were included in this study. Mean age was 
49.55 ± 16.35 years. Slightly over half (52.3%) were male. The majority of participants were 
married (75.0%), employed (64.2%), and had an education level of high school or higher 
(73.9%). Most subjects lived in urban areas (83.1%) (Table 2). 
Smoking status  
Self-reported smoking prevalence was 25.5%, whereas the prevalence of cotinine-verified 
smokers in the overall population was 29.7% (Table 2). Cotinine-verified smoking prevalence 
for men and women was 43.3% (5,578/12,875) and 9.9% (1,559/15,745), respectively (Table 
3). The overall prevalence of self-reported ex-smokers and current smokers was 18.1% and 
25.5%, the percentages were 30.6% and 43.5% in men and 4.3% and 5.9% in women (Tables 
2, 3). Of the 7,137 cotinine-verified male and female smokers, 813 (11.4%) were self-
reported non-smokers and 517 (7.2%) were self-reported ex-smokers. Specifically, 2.3% and 
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7.3% of male cotinine-verified smokers were self-reported non-smokers and ex-smokers, 
respectively, whereas 43.7% and 7.1% of female cotinine-verified smokers were self-reported 
non-smokers and ex-smokers, respectively (Table 3). The ratios of cotinine-verified to self-
reported smoking rates were 1.95 (1,559/801) for women and 1.08 (5,578/5,182) for men 
(Table 3). 
Relationship between MI or stroke and smoking  
In a univariate analysis, subjects with MI or stroke were prone to be male (p < 0.01), older 
(p < 0.01), single (separated or divorced) (p < 0.01), unemployed (p < 0.01), less educated (p 
< 0.01), obese (p < 0.01), have a lower monthly family income (p < 0.01), have fewer 
household members (p < 0.01), living in a rural setting (p < 0.01), have hypertension (p < 
0.01), and have diabetes (p < 0.01) compared to subjects without CVD (Table 4). For self-
reported smoking status, ex-smoking status was significantly correlated with CVD (p < 0.01), 
and for SCS, ex-smoking status was also correlated with CVD (p < 0.01). However, for all 
three types of smoking status, current smoking status was not significantly correlated with 
CVD using univariate statistical analysis (p > 0.05) (Table 4). 
The multivariate logistic regression analysis showed that for self-reported smoking status, 
ex-smoking status was correlated with CVD (OR: 1.62; 95% CI: 1.20–2.19). Also, for SCS, 
ex-smoking status was correlated with CVD (OR: 1.57; 95% CI: 1.20–2.19) (Table 5). 
To determine the effects of sex on smoking and CVD, sex differences were analyzed 
separately. For male participants, self-reported status and survey-cotinine-verified ex-
smoking status were correlated with CVD (OR: 1.45; 95% CI: 1.04–2.04, OR: 1.43; 95% CI: 
1.02–2.02). Female self-reported status and survey-cotinine-verified ex-smoking status were 
also correlated with CVD (OR: 2.74; 95% CI: 1.59–4.71, OR: 2.92; 95% CI: 1.64–5.18) 
(Tables 6, 7). Therefore, the current results indicate that sex affected the incidence of CVD in 
this study.  
 
Discussion 
The main findings of this study showed that, while ex-smoking status was significantly 
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associated with CVDs, current smoking status was not, and female ex-smoking status had 
higher adjusted OR for CVD than males compared to non-smoking status. In addition, there 
was an effect of hidden female smoking on the association between smoking status and CVD 
in Korean adults. 
Smoking is an established risk factor for cardiovascular morbidity and mortality [1].  
Cigarette smoke contains over 4000 compounds, many of which are extremely reactive and 
affect the physiology of several systems in the body. These compounds include nicotine, tar, 
carbon monoxide, and nitrogen oxide [14].  
Nicotine can elevate BP via various biological mechanisms: sympathomimetic action, 
modulation of the renin angiotensin system, and acute vasopressor effects. All of these 
mechanisms are associated with increases in inflammatory markers through the upregulation 
of arginine vasopressin and endothelin-1 [15]. Nicotine can also increase low-density 
lipoprotein and decrease high-density lipoprotein, thereby accelerating the progression of 
atherosclerosis [2]. 
Carbon monoxide and hemoglobin combine to produce carboxy-hemoglobin, which 
induces hypoxia, increases in the number of red blood cells, and increases in blood viscosity, 
thereby, inducing thrombosis and atherosclerosis [16]. Through these mechanisms, structural 
damage to the arterial walls from smoking is believed to cause MI and induce stroke. 
Previous studies have shown that current smoking status is significantly associated with MI 
[5, 6] and stroke [7, 17], but the present study has not shown a significant association. 
Proposed herein, is that the differing results may be due to differences in study design. The 
study design of the previous studies were case-control and population-based prospective 
cohorts; the present study design was cross-sectional. Other Korean and Polish studies that 
used cross-sectional designs showed similar results to the current study [8, 9, 18]. A Korean 
study using the 2009 Community Health Survey data gathered by the Korea Centers for 
Disease Control and Prevention showed current smoking was not associated with physician-
diagnosed MI (OR: 0.96; 95% CI: 0.82–1.12) and stroke (OR: 0.84; 95% CI: 0.74–0.94), but 
ex-smoking was associated with physician-diagnosed myocardial infarction (OR: 1.45; 95% 
CI: 1.26–1.67) and stroke (OR: 1.38; 95% CI: 1.24–1.53) [9]. In the Polish study, the 
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researchers showed a significant association between former smokers and CVD (OR: 1.33; 
95% CI: 1.05–1.68), but not between current smokers and CVD (OR: 1.06; 95% CI: 0.77–
1.47) [18]. In addition, after cardiovascular events, patients were advised to quit smoking by 
physicians [19]. Therefore, the idea that cross-sectional studies, including the present study, 
might show no association between current smoking and CVD, but a significant association 
between ex-smoking and CVD. 
For stroke, previous Korean studies showed different results. One study showed that ex-
smoking status was associated with stroke in Korean male adults, but current smoking was 
not [9]. Another study showed that current smoking status was associated with stroke (OR: 
1.060; 95% CI: 1.022–1.100) [8]. Because the prevalence of stroke increases with age, it was 
assumed these differing results may be due to differences in participant age. One study 
included male subjects 30 years or older [9], while another study included subjects 50 years 
or older [8]. In the current study, participants 19 years or older were included and showed that 
ex-smoking status, but not current smoking status, was associated with stroke.  
In the present study, female ex-smoking status had higher odds ratio for CVD than males, 
compared to non-smoking status. Two hypotheses are herein proposed. First, the use of oral 
contraceptives and postmenopausal hormone replacement therapy in female smokers might 
increase CVD incidence, and the association between ex-smoker and CVD might be higher in 
female smokers due to smoking cessation after a CVD attack. The use of oral contraceptives 
and postmenopausal hormonal replacement therapy in smokers was known to increase the 
risk of MI and stroke [20–22]. Although the use of oral contraceptives did not increase the 
risk of MI in non-smokers, the use of oral contraceptives significantly increased the risk of 
MI in smokers [23]. The use of oral contraceptives also showed a higher prevalence of stroke 
in smokers compared to non-smokers [20], and the use of postmenopausal hormonal 
replacement therapy showed the same results for MI and stroke [21, 22]. Second, it was 
assumed these effects might be due to more female hidden smokers than males. In the case of 
self-reported ex-smokers, the probability of being identified as cotinine-verified smokers was 
10.46% for men and 18.6% for women. 
In the present study, the ratios of cotinine-verified to self-reported smoking rates were 1.95 
for women and 1.08 for men. These rates were similar to the findings of a previous Korean 
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study [10]. That study reported that ratios of cotinine-verified to self-reported smoking rates 
were 2.36 for women and 1.12 for men [10], but studies in other countries reported no sex 
differences in underreporting the rate of smoking history [24, 25].  
In a study from the United States, the rates of agreement between self-reported and 
cotinine-verified smokers were 91.6% for women and 89.7% for men [24]. Additionally, a 
study from Finland documented that 2.5% of men and 2.7% of women who self-reported as 
non-smokers had positive serum cotinine levels [25]. 
This result means there were more hidden female smokers than hidden male smokers in the 
current study. It was assumed that self-reported smoking in Korean women underestimates 
the true prevalence as a result of Confucianism. The adoption of Confucianism can result in a 
patriarchal culture in which female smoking is stigmatized [26]. The discrepancy in the 
underreporting rates between the sexes could lead to statistical inconsistencies.  
To better understand the association between CVD and smoking, a new variable was 
created; SCS, in order to consider the effects of hidden smoking and other types of smoking. 
This new variable showed similar results compared to self-reported smoking status. 
Therefore, it isplausable to suggest that passive and light smoking may affect CVD 
development and are similar to affects of active smoking. 
Light and social smokers often are not detected; many of these individuals have the 
perception of being non-smokers [27, 28]. However, a recent study reported that social 
smokers had significantly higher risks of CVD than non-smokers. Moreover, no significant 
differences in the development of hypertension have been reported between social smokers 
and current smokers [29]. Another report showed that light smoking was associated with a 
significantly higher risk of dying from ischemic heart disease [30]. With respect to the 
relationship between CVD and social and light smoking, a stable pattern of chronic low-level 
consumption may be assumed to have similar effects on CVD as constant, current active 
smoking. 
Limitations of the study 
There are several limitations to this study. First, because this study was based on a survey, 
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there may be selection and recall biases. Second, because this study was cross-sectional in 
design,  a causal relationship between smoking and CVD could not be confirmed. Third, 
although CVD was defined as MI and stroke in this study, CVD also includes other coronary 
heart diseases such as angina and peripheral arterial diseases; this was considered to be a 
limitation in the present study. Finally, potential confounding factors, including amount and 
duration of smoking, diet patterns, and genetic or sex variations affecting nicotine 
metabolism, still exist. Further prospective and collaborative worldwide studies are needed to 
clarify the effect of hidden female smoking on CVD. However, the strength of this study is its 
use of nationally and widely sampled data to assess sex-specific relationships between 
smoking status and CVD through the creation of a new variable, SCS. This new variable was 
used to evaluate the effect of hidden smoking on CVD.  
 
Statement of ethics 
This study was approved by the Institutional Review Board (IRB) of Samsung Changwon 
Hospital (IRB No: SCMC2019-04-005). Informed consent was waived by the board. 
 
Conclusions 
This large observational study found that ex-smoking status was associated with CVD and 
female ex-smoking status had a higher adjusted OR for CVD than males compared to non-
smoking status. In addition, there was an effect of hidden female smoking on the association 
between smoking status and CVD in Korean adults. 
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Table 1. Definition of survey-cotinine-verified smoking status (SCS). 
Self-reported smoking status Cotinine-verified smoking status 
 Non-smoker (≤ 50 ng/mL) Smoker (> 50 ng/mL) 
 
Non-smoker Non-smoker (n = 16,595) Smoker (n = 813) 
Ex-smoker Ex-smoker (n = 4712) Smoker (n = 517) 
Smoker Smoker (n = 176) Smoker (n = 5,807) 
 
 
Table 2. Demographic characteristics of subjects. 
Characteristics Sample size Estimate % (95% CI) 
Sex (n = 28,620)   
Male 12,875  52.29 (51.74–52.85) 
Female 15,745  47.71 (47.15–48.26) 
Age (n = 28,620)   
< 50 14,332  62.00 (61.04–62.97) 
50–59 5515  18.89 (18.27–19.51) 
60–69 5000  11.30 (10.85–11.77) 
≥ 70 3773  7.81 (7.41–8.24) 
Marital status (n = 26,740)   
Married 20,644  74.95 (74.03–75.84) 
Single (separated or divorced) 3491  10.10 (9.61–10.62) 
Never-married 2605  14.95 (14.15–15.80) 
Employment status (n = 28,541)   
Employed 17,307  64.19 (63.40–64.97) 
Unemployed 11,234  35.81 (35.03–36.60) 
Education level (n = 28,541)   
< High school 9918  26.10 (25.18–27.05) 
High school 9755  38.94 (38.08–39.80) 
> High school 8868  34.96 (33.89–36.04) 
Monthly family income (n = 28,310)   
< 25th 5284  14.80 (14.06–15.57) 
25–50th 7149  24.85 (23.96–25.76) 
50–75th 7851  29.64 (28.68–30.61) 
≥ 75th 8026  30.72 (29.40–32.06) 
Number of household members (n = 28,608) 
1 2521  7.26 (6.68–7.88) 
2 7695  21.58 (20.84–22.33) 
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3 6968  26.67 (25.82–27.54) 
4 7725  30.92 (29.95–31.91) 
≥ 5 3699  13.58 (12.80–14.39) 
Residence area (n = 28,620)   
Urban 22,156  83.14 (81.04–85.05) 
Rural 6104  16.86 (14.95–18.96) 
Smoking status   
Self-reported 1 (n = 28,620)   
Non-smoker 17,408  56.41 (55.73–57.09) 
Ex-smoker 5229  18.05 (17.55–18.56) 
Smoker 5983  25.54 (24.87–26.22) 
Cotinine-verified (n = 28,620)   
Non-smoker 21,483  70.33 (69.58–71.07) 
Smoker 7137  29.67 (28.93–30.42) 
Survey-cotinine verified (n = 28,620)   
Non-smoker 16,595  53.57 (52.85–54.29) 
Ex-smoker 4712  15.98 (15.49–16.47) 
Smoker 7313  30.45 (29.72–31.20) 
Body mass index (n = 28,620)   
< 23 12,318  43.64 (42.90–44.37) 
23–25 6812  23.71 (23.13–24.30) 
≥ 25 9415  32.66 (31.95–33.37) 
Hypertension (n = 28,620) 7917  23.69 (23.04–24.36) 
Diabetes (n = 28,620) 3082  8.80 (8.42–9.20) 
Myocardial infarct or stroke (n = 
28,620) 
811  1.98 (1.81–2.16) 
Myocardial infarct 236  0.60 (0.51–0.70) 
Stroke 599  1.44 (1.30–1.60) 
 
 
Table 3. Self-reported and cotinine-verified smoking status in male and female participants. 
Self-reported smoking status  
Cotinine-verified smoking status 
(estimate % [95% CI]) 
 Total Non-smoker Smoker 
Male (n = 12,875)    
Total  53.4 (52.3–54.4) 46.6 (45.6–47.7) 
Non-smoker 26.0 (25.0–26.9) 24.8 (23.9–25.7) 1.2 (1.0–1.4) 
Ex-smoker 30.6 (29.6–31.5) 27.4 (26.5–28.3) 3.2 (2.9–3.6) 
Smoker 43.5 (42.4–44.5) 1.2 (1.0–1.5) 42.3 (41.2–43.3) 
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Female (n = 15,745)    
Total  88.9 (88.2–89.6) 11.1 (10.4–11.8) 
Non-smoker 89.8 (89.1–90.4) 85.1 (84.3–85.9) 4.7 (4.2–5.2) 
Ex-smoker 4.3 (4.0–4.8) 3.5 (3.2–3.9) 0.8 (0.7–1.0) 
Smoker 5.9 (5.4–6.4) 0.3 (0.2–0.4) 5.6 (5.1–6.1) 
 
 
 
Table 4. Crude odds ratios and 95% confidence intervals (CI) for myocardial infarction and stroke 
prevalence. 
Characteristics Odds ratio (95%CI) 
 Total Male Female 
Sex    
Male 1.40 (1.19–1.65) – – 
Female Reference – – 
Age    
< 50 Reference Reference Reference 
50–59 8.10 (5.48–11.96) 7.65 (4.78–12.24) 11.07 (5.45–22.47) 
60–69 
21.90 (15.38–
31.19) 
21.03 (13.81–
32.02) 
31.48 (16.18–
61.26) 
≥ 70 
33.92 (24.05–
47.85) 
28.01 (18.40–
42.64) 
63.78 (33.44–
121.65) 
Marital status    
Married Reference Reference Reference 
Single (separated or 
divorced) 
2.28 (1.87–2.80) 1.94 (1.30–2.87) 3.48 (2.70–4.49) 
Never-married 0.15 (0.08–0.29) 0.15 (0.07–0.31) 0.10 (0.02–0.40) 
Employment status    
Employed Reference Reference Reference 
Unemployed 2.98 (2.50–3.55) 3.74 (2.99–4.68) 3.44 (2.61–4.55) 
Education    
< High school 8.62 (6.45–11.50) 7.44 (5.33–10.39) 
20.45 (10.76–
38.86) 
High school 1.90 (1.37–2.63) 1.83 (1.27–2.64) 2.62 (1.31–5.24) 
> High school Reference Reference Reference 
Monthly family income    
< 25th 6.30 (4.78–8.30) 5.70 (4.04–8.04) 9.06 (5.89–13.92) 
25–50th 2.13 (1.58–2.87) 1.80 (1.24–2.61) 3.17 (2.01–5.00) 
50–75th 1.44 (1.06–1.96) 1.24 (0.85–1.82) 2.01 (1.23–3.26) 
≥ 75th Reference Reference Reference 
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Number of household members 
1 2.25 (1.60–3.18) 1.29 (0.74–2.18) 3.91 (2.36–6.47) 
2 2.40 (1.79–3.22) 2.34 (1.62–3.40) 2.50 (1.56–3.99) 
3 0.93 (0.67–1.30) 0.91 (0.60–1.38) 0.92 (0.55–1.54) 
4 0.56 (0.39–0.80) 0.56 (0.36–0.89) 0.50 (0.27–0.91) 
≥ 5 Reference Reference Reference 
Residence area    
Urban Reference Reference Reference 
Rural 1.53 (1.25–1.87) 1.39 (1.07–1.81) 1.74 (1.33–2.29) 
Smoking status    
Self-reported     
Non-smoker Reference Reference Reference 
Ex-smoker 2.69 (2.24–3.24) 3.30 (2.43–4.49) 2.00 (1.26–3.16) 
Smoker 0.99 (0.79–1.24) 1.23 (0.87–1.72) 0.61 (0.35–1.08) 
Cotinine-verified    
Non–smoker Reference Reference Reference 
Smoker  0.67 (0.55–0.83) 0.56 (0.43–0.71) 0.50 (0.32–0.79) 
Survey-cotinine verified     
Non-smoker Reference Reference Reference 
Ex-smoker 2.79 (2.30–3.38) 3.37 (2.46–4.60) 2.25 (1.39–3.63) 
Smoker 0.92 (0.74–1.15) 1.19 (0.85–1.67) 0.53 (0.34–0.84) 
Body mass index    
< 23 Reference Reference Reference 
23–25 1.49 (1.19–1.87) 1.13 (0.84–1.51) 1.98 (1.42–2.77) 
≥ 25 1.88 (1.55–2.29) 1.35 (1.03–1.77) 2.70 (2.02–3.59) 
Hypertension    
No Reference Reference Reference 
Yes 5.60 (4.71–6.67) 4.24 (3.34–5.38) 8.18 (6.24–10.74) 
Diabetes    
No Reference Reference Reference 
Yes 5.36 (4.47–6.42) 5.89 (4.62–7.50) 4.41 (3.36–5.78) 
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Table 5. Adjusted odds ratios and 95% confidence intervals for myocardial infarction and stroke 
prevalence. 
Characteristics Self–reported  
Cotinine–
verified 
Survey–cotinine 
verified 
Sex    
Male 1.70 (1.26–2.27) 2.39 (1.93–2.94) 1.78 (1.35–2.35) 
Female Reference Reference Reference 
Age    
< 50 Reference Reference Reference 
50–59 4.88 (3.12–7.65) 4.89 (3.11–7.69 4.84 (3.09–7.59) 
60–69 8.52 (5.41–13.44) 
8.52 (5.38–
13.48) 
8.42 (5.33–
13.30) 
≥ 70 9.81 (6.05–15.92) 
9.78 (6.01–
15.92) 
9.64 (5.93–
15.67) 
Marital status    
Married Reference Reference Reference 
Single (separated or 
divorced) 
0.97 (0.73–1.28) 0.99 (0.75–1.30) 0.97 (0.74–1.28) 
Never-married 0.75 (0.36–1.54) 0.69 (0.34–1.43) 0.74 (0.36–1.52) 
Employment status    
Employed Reference Reference Reference 
Unemployed 1.90 (1.55–2.33) 1.93 (0.57–2.38) 1.90 (1.55–2.34) 
Education    
< High school 1.78 (1.29–2.45) 1.80 (1.30–2.48) 1.79 (1.30–2.47) 
High school 1.36 (0.96–1.93) 1.38 (0.98–1.94) 1.37 (0.97–1.93) 
> High school Reference Reference Reference 
Monthly family income    
< 25th 1.69 (1.24–2.30) 1.70 (1.25–2.32) 1.70 (1.25–2.32) 
25–50th 1.25 (0.91–1.72) 1.25 (0.91–1.72) 1.25 (0.91–1.72) 
50–75th 1.27 (0.92–1.76) 1.28 (0.93–1.77) 1.27 (0.92–1.76) 
≥ 75th Reference Reference Reference 
Number of household members 
1 0.94 (0.65–1.37) 0.95 (0.65–1.38) 0.94 (0.65–1.38) 
2 0.95 (0.68–1.32) 0.96 (0.69–1.34) 0.95 (0.68–1.33) 
3 0.82 (0.58–1.17) 0.82 (0.58–1.18) 0.82 (0.58–1.18) 
4 0.82 (0.56–1.20) 0.82 (0.56–1.20) 0.82 (0.56–1.21) 
≥ 5 Reference Reference Reference 
Residence area    
Urban Reference Reference Reference 
Rural 1.13 (0.91–1.40) 1.12 (0.90–1.39) 1.13 (0.91–1.40) 
Smoking status    
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Self-reported     
Non-smoker Reference – – 
Ex-smoker 1.62 (1.20–2.19) – – 
Smoker 1.25 (0.92–1.70) – – 
Cotinine-verified    
Non-smoker – Reference – 
Smoker – 0.88 (0.69–1.11) – 
Survey-cotinine verified    
Non-smoker – – Reference 
Ex-smoker – – 1.57 (1.16–2.12) 
Smoker – – 1.15 (0.87–1.53) 
Body mass index    
< 23 Reference Reference Reference 
23–25 1.10 (1.20–2.19) 1.10 (0.87–1.40) 1.10 (0.86–1.40) 
≥ 25 1.25 (0.92–1.70) 1.24 (0.99–1.56) 1.24 (0.99–1.56) 
Hypertension    
No Reference Reference Reference 
Yes 2.06 (1.69–2.50) 2.05 (1.69–2.50) 2.05 (1.69–2.49) 
Diabetes    
No Reference Reference Reference 
Yes 1.85 (1.52–2.25) 1.86 (1.53–2.27) 1.85 (1.52–2.26) 
*Adjusted for sex, age, marital status, employment status, education level, monthly family income, 
number of household members, residence area, smoking status, body mass index, hypertension and 
diabetes. 
 
 
Table 6. Adjusted odds ratios and 95% confidence intervals for myocardial infarction and stroke 
prevalence in male participants. 
Characteristics Self–reported  
Cotinine–
verified 
Survey–cotinine 
verified  
Age    
< 50 Reference Reference Reference 
50–59 4.63 (2.66–8.06) 4.70 (2.70–8.20) 4.60 (2.64–8.01) 
60–69 
8.65 (4.93–
15.18) 
8.80 (5.01–
15.45) 
8.57 (4.87–
15.07) 
≥ 70 
8.09 (4.33–
15.10) 
8.17 (4.37–
15.27) 
7.97 (4.25–
14.94) 
Marital status    
Married Reference Reference Reference 
Single (separated or divorced) 1.01 (0.62–1.65) 1.02 (0.63–1.67) 1.01 (0.62–1.65) 
20 
 
Never-married 0.72 (0.30–1.74) 0.67 (0.28–1.61) 0.72 (0.30–1.72) 
Employment status    
Employed Reference Reference Reference 
Unemployed 1.92 (1.44–2.56) 1.96 (1.47–2.61) 1.93 (1.45–2.57) 
Education    
< High school 1.74 (1.20–2.52) 1.76 (1.22–2.55) 1.75 (1.21–2.53) 
High school 1.39 (0.93–2.07) 1.40 (0.94–2.09) 1.39 (0.93–2.08) 
> High school Reference Reference Reference 
Monthly family income    
< 25th 1.71 (1.14–2.57) 1.71 (1.14–2.57) 1.72 (1.15–2.58) 
25–50th 1.11 (0.75–1.65) 1.11 (0.74–1.65) 1.11 (0.75–1.66) 
50–75th 1.15 (0.77–1.72) 1.15 (0.77–1.73) 1.15 (0.76–1.72) 
≥ 75th Reference Reference Reference 
Number of household members    
1 0.77 (0.41–1.45) 0.78 (0.41–1.46) 0.77 (0.41–1.45) 
2 0.90 (0.59–1.38) 0.92 (0.60–1.40) 0.91 (0.59–1.39) 
3 0.78 (0.50–1.22) 0.78 (0.50–1.23) 0.78 (0.50–1.23) 
4 0.84 (0.52–1.36) 0.85 (0.52–1.37) 0.85 (0.52–1.37) 
≥ 5 Reference Reference Reference 
Residence area    
Urban Reference Reference Reference 
Rural 1.07 (0.80–1.42) 1.06 (0.80–1.41) 1.07 (0.80–1.42) 
Smoking status    
Self-reported     
Non-smoker Reference – – 
Ex-smoker 1.45 (1.04–2.04) – – 
Smoker 1.17 (0.81–1.67) – – 
Cotinine-verified    
Non-smoker – Reference – 
Smoker – 0.87 (0.65–1.15) – 
Survey-cotinine verified     
Non-smoker – – Reference 
Ex-smoker – – 1.43 (1.02–2.02) 
Smoker – – 1.12 (0.78–1.60) 
Body mass index    
< 23 Reference Reference Reference 
23–25 1.11 (0.80–1.53) 1.11 (0.80–1.54) 1.10 (0.80–1.53) 
≥ 25 1.37 (0.99–1.89) 1.37 (0.99–1.89) 1.36 (0.98–1.89) 
Hypertension    
No Reference Reference Reference 
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Yes 1.84 (1.41–2.40) 1.85 (1.41–2.41) 1.84 (1.41–2.39) 
Diabetes    
No Reference Reference Reference 
Yes 2.26 (1.72–2.97) 2.29 (1.74–3.01) 2.26 (1.72–2.98) 
*Adjusted for age, marital status, employment status, education level, monthly family income, 
number of household members, residence area, smoking status, body mass index, hypertension and 
diabetes. 
 
 
Table 7. Adjusted odds ratios and 95% confidence intervals for myocardial infarction and stroke 
prevalence in female participants. 
  Characteristics Self-reported  
Cotinine-
verified 
Survey-cotinine 
verified  
Age    
< 50 Reference Reference Reference 
50–59 
5.46 (2.32–
12.87) 
4.98 (2.11–
11.77) 
5.35 (2.27–
12.57) 
60–69 
8.80 (3.58–
21.64) 
7.87 (3.18–
19.49) 
8.56 (3.49–
20.99) 
≥ 70 
13.25 (5.28–
33.30) 
11.91 (4.71–
30.12) 
12.83 (5.13–
32.11) 
Marital status    
Married Reference Reference Reference 
Single (separated or divorced) 0.86 (0.60–1.23) 0.91 (0.65–1.29) 0.87 (0.61–1.24) 
Never-married 0.74 (0.17–3.25) 0.75 (0.16–3.45) 0.74 (0.17–3.20) 
Employment status    
Employed Reference Reference Reference 
Unemployed 2.00 (1.46–2.74) 2.04 (1.49–2.80) 2.01 (1.47–2.76) 
Education    
< High school 2.06 (0.99–4.29) 2.09 (1.01–4.35) 2.08 (1.01–4.33) 
High school 143 (0.71–2.88) 1.44 (0.72–2.90) 1.45 (0.72–2.92) 
> High school Reference Reference Reference 
Monthly family income    
< 25th 1.79 (1.09–2.91) 1.84 (1.13–3.00) 1.80 (1.10–2.94) 
25–50th 1.62 (0.98–2.67) 1.61 (0.98–2.66) 1.63 (0.99–2.68) 
50–75th 1.59 (0.95–2.67) 1.61 (0.96–2.69) 1.60 (0.95–2.67) 
≥ 75th Reference Reference Reference 
Number of household members    
1 1.12 (0.63–1.98) 1.11 (0.63–1.94) 1.12 (0.63–1.98) 
2 1.06 (0.61–1.85) 1.06 (0.61–1.84) 1.07 (0.61–1.86) 
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3 0.91 (0.51–1.64) 0.90 (0.50–1.61) 0.92 (0.51–1.65) 
4 0.77 (0.40–1.49) 0.76 (0.40–1.46) 0.78 (0.40–1.49) 
≥ 5 Reference Reference Reference 
Residence area    
Urban Reference Reference Reference 
Rural 1.21 (0.90–1.63) 1.19 (0.88–1.59) 1.21 (0.90–1.63) 
Smoking status    
Self-reported    
Non-smoker Reference – – 
Ex-smoker 2.74 (1.59–4.71) – – 
Smoker 0.96 (0.53–1.72) – – 
Cotinine-verified    
Non-smoker – Reference – 
Smoker – 1.19 (0.88–1.59) – 
Survey-cotinine verified    
Non-smoker – – Reference 
Ex-smoker – – 2.92 (1.64–5.18) 
Smoker – – 0.90 (0.56–1.44) 
Body mass index    
< 23 Reference Reference Reference 
23–25 1.09 (0.77–1.56) 1.08 (0.76–1.54) 1.08 (0.76–1.54) 
≥ 25 1.05 (0.77–1.44) 1.06 (0.78–1.44) 1.05 (0.77–1.43) 
Hypertension    
No Reference Reference Reference 
Yes 2.43 (1.80–3.28) 2.41 (1.78–3.25) 2.43 (1.80–3.28) 
Diabetes    
No Reference Reference Reference 
Yes 1.29 (0.97–1.74) 1.31 (0.98–1.75) 1.29 (0.96–1.73) 
*Adjusted for age, marital status, employment status, education level, monthly family income, 
number of household members, residence area, smoking status, body mass index, hypertension and 
diabetes. 
 
